Endothelin receptor antagonists: Medikamente News - Info Netzwerk Medizin 2000  
Pulmonary arterial hypertension therapy. Info Netzwerk Medizin 2000      
Primary Pulmonary Hypertension (PPH) 
 
 


Startseite
Profieingang mit Passwortschutz
Nutzungsbedingungen
Readaktion Info-Netzwerk Medizin 2000
Kontakt Info-Netzwerk Medizin 2000

 

 


ASK THE EXPERT

If you would like to pose a question on pulmonary arterial hypertension to one of the panel, please select the appropriate expert or experts below by clicking on their photograph.

Every effort will be taken to respond to your question within the next 12 days.



 

Carol Black CBE, MD Carol Black CBE, MD
Royal Free Hospital and University College
London, UK

Carol Black, MD is Professor of Rheumatology and Director of the Centre for Rheumatology at the Royal Free & University College Medical School in London, UK. She is President of the Royal College of Physicians of London and a member of several professional societies and committees. Prof. Black has led the scleroderma trials for the European League Against Rheumatism (EULAR) Committee for Clinical Studies and is Chairwoman and Founder of the European Scleroderma Club. At the Royal Free Hospital, Prof. Black's Unit is the major centre for scleroderma in Europe and one of the largest in the world with an extensive programme of clinical and basic research. In recognition of her work in scleroderma she was recently awarded a CBE (Commander of the British Empire).
     
Christopher Denton MD Christopher Denton MD
Royal Free Hospital and University College
London, UK

Christopher Denton, MD, is currently Senior Lecturer at London’s University College and Rheumatologist Consultant at the Centre OF Rheumatology, Royal Free Hospital, London, UK. He received his PhD in Medicine and Cell Biology at the University of London in 1997, and his speciality credentials in Rheumatology in 1998. His appointments have included Senior Registrar in Rheumatology at the Royal Free Hospital in London and Postdoctoral Research Fellow in molecular Genetics at the University of Texas M. D .Anderson Cancer Center in Houston, USA from 1997 - 1999. Dr Denton’s research has focused on the role of endothelin-1 in connective tissue disease pathogenesis, specifically with regard to scleroderma fibroblasts.
     
Nazzareno Galiè MD Nazzareno Galiè MD
Institute of Cardiology, University of Bologna
Bologna, Italy

Dr. Nazzareno Galiè heads the Pulmonary Hypertension Unit at the Institute of Cardiology of the University of Bologna in Bologna, Italy. He is also Professor of Cardiovascular Diseases at the Postgraduate Medical School of Pulmonary Diseases, and at the Postgraduate Medical School of Cardiology at the University of Bologna. He has authored more than 250 scientific publications on heart failure, heart transplantation and pulmonary hypertension. He is currently serving as Chairman of the Working Group on Pulmonary Circulation and Right Ventricular Function and as member of the Scientific Council of the European Society of Cardiology. He is also a Fellow of the Italian Society of Cardiology and of the European Society of Cardiology.
     
Marius M. Hoeper MD Marius M. Hoeper MD
University of Hannover Medical School
Hannover, Germany

Marius M. Hoeper, MD, was educated at the Medizinische Hochschule in Hannover, where he specialized in respiratory medicine. He received a two-year grant at the University of Colorado, Denver, USA in 1992 from Germany’s National Research Foundation. Since 2001, Prof. Hoeper holds the position of Senior Physician in the Department of Pneumology at the Medizinische Hochschule in Hanover.
     
Lewis J. Rubin MD Lewis J. Rubin MD
University of California, San Diego School of Medicine
La Jolla, California, USA

Lewis J. Rubin, MD is currently Director, Pulmonary Vascular Center and Professor of Medicine at the University of California, San Diego School of Medicine in La Jolla, California, USA. Dr. Rubin has been involved in basic and clinical investigation and direct patient care with pulmonary vascular diseases for over twenty years. He is the author of over 130 peer-reviewed scientific papers, including reviews of pulmonary vascular disease in the New England Journal of Medicine and the Lancet, and over 50 book chapters including sections on pulmonary hypertension in many of the leading textbooks of medicine, cardiology, critical care medicine and respiratory medicine. In addition to his academic appointments, Dr. Rubin is a member of several societies including the American College of Physicians, has an honorary fellowship at the Royal College of Physicians of the United Kingdom and serves on the Cardiopulmonary Council of the American Heart Association. His research interests include pulmonary circulation, pulmonary physiology, and cardiopulmonary inter-relationships.
     
Gérald Simonneau MD Gérald Simonneau MD
Hôpital Antoine Béclère
Clamart, France

Gérald Simonneau, MD is Chief, Department of Pneumology, Hôpital Antoine Béclère, Clamart, France. In addition, Professor Simonneau is Vice President and next elected President of the Working Group on Pulmonary Circulation of the European Society of Cardiology. He has widely published in the fields of pulmonary hypertension, pulmonary vascular diseases, and pneumology. Professor Simonneau has also been the Director of the Unité Propre de Recherche de l’Enseignement Supérieur on pulmonary vascular diseases since 1998.

 


 

www.traxglobal.com

 

 

www.tracleer.com   (USA)

 

 

www.actelion.com

 

 

Pulmonary arterial hypertension therapy: Medikamente News - Info Netzwerk Medizin 2000
 
| Adipositas Therapie | AIDS/HIV | Allergie Therapie | allergisches Asthma | Antibabypille |
| Asthma Therapie | Betablocker Therapie | COPD | Diabetes | Erektile Dysfunktion |
| Evidence based Medicine | Frauenheilkunde | Grippe | Haarausfall Therapie |
| Hausstauballergie | Herzkrankheiten | Herzinsuffizienz Diagnose | Herzinsuffizienz |
| Herzschrittmacher | Highlights Forschung | Humangenetik | Hundehaarallergie |
| Hypertonie | Impotenz Therapie | Impfen | Insektengiftallergie | Insulin Therapie |
| Kardiologie | Katzenhaarallergie | Komplementärmedizin | Krankenhäuser | Krebs |
| Magenleiden | Medikamente | Medizintechnik | Mistel Therapie | Naturheilverfahren |
| Nervenkrankheiten | online Hausarzt | Orthopädie | Osteoporose | Pollenallergie |
| PAH | Pressearchiv | Presseerklärungen | Reisewebsite | Report Medizin | Rheuma |
| Schmerz | Sportmedizin | Tierhaarallergie | Totalendoprothese | Zuckerkrankheit |
| | Medizin 2000 | Impressum | Nutzungsbedingungen | Stichwortsuche |

 

 e-mail us

Navigationspfeil top

Endothelin: Medikamente News - Info Netzwerk Medizin 2000
Copyright ©  LaHave Media Services Limited
ASK THE EXPERT. Therapy of pulmonary arterial hypertensin with Bosentan, Tracleer.Medikamente News. Info-Netzwerk Medizin 2000
Endothelin receptor antagonists: Medikamente News - Info Netzwerk Medizin 2000  
Pulmonary arterial hypertension therapy. Info Netzwerk Medizin 2000      
Primary Pulmonary Hypertension (PPH) 
 
 


Startseite
Profieingang mit Passwortschutz
Nutzungsbedingungen
Readaktion Info-Netzwerk Medizin 2000
Kontakt Info-Netzwerk Medizin 2000

 

 


ASK THE EXPERT

If you would like to pose a question on pulmonary arterial hypertension to one of the panel, please select the appropriate expert or experts below by clicking on their photograph.

Every effort will be taken to respond to your question within the next 12 days.



 

Carol Black CBE, MD Carol Black CBE, MD
Royal Free Hospital and University College
London, UK

Carol Black, MD is Professor of Rheumatology and Director of the Centre for Rheumatology at the Royal Free & University College Medical School in London, UK. She is President of the Royal College of Physicians of London and a member of several professional societies and committees. Prof. Black has led the scleroderma trials for the European League Against Rheumatism (EULAR) Committee for Clinical Studies and is Chairwoman and Founder of the European Scleroderma Club. At the Royal Free Hospital, Prof. Black's Unit is the major centre for scleroderma in Europe and one of the largest in the world with an extensive programme of clinical and basic research. In recognition of her work in scleroderma she was recently awarded a CBE (Commander of the British Empire).
     
Christopher Denton MD Christopher Denton MD
Royal Free Hospital and University College
London, UK

Christopher Denton, MD, is currently Senior Lecturer at London’s University College and Rheumatologist Consultant at the Centre OF Rheumatology, Royal Free Hospital, London, UK. He received his PhD in Medicine and Cell Biology at the University of London in 1997, and his speciality credentials in Rheumatology in 1998. His appointments have included Senior Registrar in Rheumatology at the Royal Free Hospital in London and Postdoctoral Research Fellow in molecular Genetics at the University of Texas M. D .Anderson Cancer Center in Houston, USA from 1997 - 1999. Dr Denton’s research has focused on the role of endothelin-1 in connective tissue disease pathogenesis, specifically with regard to scleroderma fibroblasts.
     
Nazzareno Galiè MD Nazzareno Galiè MD
Institute of Cardiology, University of Bologna
Bologna, Italy

Dr. Nazzareno Galiè heads the Pulmonary Hypertension Unit at the Institute of Cardiology of the University of Bologna in Bologna, Italy. He is also Professor of Cardiovascular Diseases at the Postgraduate Medical School of Pulmonary Diseases, and at the Postgraduate Medical School of Cardiology at the University of Bologna. He has authored more than 250 scientific publications on heart failure, heart transplantation and pulmonary hypertension. He is currently serving as Chairman of the Working Group on Pulmonary Circulation and Right Ventricular Function and as member of the Scientific Council of the European Society of Cardiology. He is also a Fellow of the Italian Society of Cardiology and of the European Society of Cardiology.
     
Marius M. Hoeper MD Marius M. Hoeper MD
University of Hannover Medical School
Hannover, Germany

Marius M. Hoeper, MD, was educated at the Medizinische Hochschule in Hannover, where he specialized in respiratory medicine. He received a two-year grant at the University of Colorado, Denver, USA in 1992 from Germany’s National Research Foundation. Since 2001, Prof. Hoeper holds the position of Senior Physician in the Department of Pneumology at the Medizinische Hochschule in Hanover.
     
Lewis J. Rubin MD Lewis J. Rubin MD
University of California, San Diego School of Medicine
La Jolla, California, USA

Lewis J. Rubin, MD is currently Director, Pulmonary Vascular Center and Professor of Medicine at the University of California, San Diego School of Medicine in La Jolla, California, USA. Dr. Rubin has been involved in basic and clinical investigation and direct patient care with pulmonary vascular diseases for over twenty years. He is the author of over 130 peer-reviewed scientific papers, including reviews of pulmonary vascular disease in the New England Journal of Medicine and the Lancet, and over 50 book chapters including sections on pulmonary hypertension in many of the leading textbooks of medicine, cardiology, critical care medicine and respiratory medicine. In addition to his academic appointments, Dr. Rubin is a member of several societies including the American College of Physicians, has an honorary fellowship at the Royal College of Physicians of the United Kingdom and serves on the Cardiopulmonary Council of the American Heart Association. His research interests include pulmonary circulation, pulmonary physiology, and cardiopulmonary inter-relationships.
     
Gérald Simonneau MD Gérald Simonneau MD
Hôpital Antoine Béclère
Clamart, France

Gérald Simonneau, MD is Chief, Department of Pneumology, Hôpital Antoine Béclère, Clamart, France. In addition, Professor Simonneau is Vice President and next elected President of the Working Group on Pulmonary Circulation of the European Society of Cardiology. He has widely published in the fields of pulmonary hypertension, pulmonary vascular diseases, and pneumology. Professor Simonneau has also been the Director of the Unité Propre de Recherche de l’Enseignement Supérieur on pulmonary vascular diseases since 1998.

 


 

www.traxglobal.com

 

 

www.tracleer.com   (USA)

 

 

www.actelion.com

 

 

Pulmonary arterial hypertension therapy: Medikamente News - Info Netzwerk Medizin 2000
 
| Adipositas Therapie | AIDS/HIV | Allergie Therapie | allergisches Asthma | Antibabypille |
| Asthma Therapie | Betablocker Therapie | COPD | Diabetes | Erektile Dysfunktion |
| Evidence based Medicine | Frauenheilkunde | Grippe | Haarausfall Therapie |
| Hausstauballergie | Herzkrankheiten | Herzinsuffizienz Diagnose | Herzinsuffizienz |
| Herzschrittmacher | Highlights Forschung | Humangenetik | Hundehaarallergie |
| Hypertonie | Impotenz Therapie | Impfen | Insektengiftallergie | Insulin Therapie |
| Kardiologie | Katzenhaarallergie | Komplementärmedizin | Krankenhäuser | Krebs |
| Magenleiden | Medikamente | Medizintechnik | Mistel Therapie | Naturheilverfahren |
| Nervenkrankheiten | online Hausarzt | Orthopädie | Osteoporose | Pollenallergie |
| PAH | Pressearchiv | Presseerklärungen | Reisewebsite | Report Medizin | Rheuma |
| Schmerz | Sportmedizin | Tierhaarallergie | Totalendoprothese | Zuckerkrankheit |
| | Medizin 2000 | Impressum | Nutzungsbedingungen | Stichwortsuche |

 

 e-mail us

Navigationspfeil top

Endothelin: Medikamente News - Info Netzwerk Medizin 2000
Copyright ©  LaHave Media Services Limited